This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.Need a new registration confirmation email? Click here

3 Drugs Stocks On The Rise

2. As of noon trading,
Amgen (
AMGN) is up $2.87 (2.4%) to $125.13 on average volume. Thus far, 2.0 million shares of Amgen exchanged hands as compared to its average daily volume of 3.2 million shares. The stock has ranged in price between $122.25-$126.10 after having opened the day at $122.26 as compared to the previous trading day's close of $122.26.

Amgen Inc., a biotechnology company, discovers, develops, manufactures, and delivers human therapeutics in the areas of oncology, hematology, inflammation, bone health, nephrology, cardiovascular, and general medicine worldwide. Amgen has a market cap of $93.8 billion and is part of the health care sector. Shares are up 8.9% year-to-date as of the close of trading on Friday. Currently there are 7 analysts who rate Amgen a buy, no analysts rate it a sell, and 12 rate it a hold.

TheStreet Ratings rates
Amgen as a
buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, impressive record of earnings per share growth, compelling growth in net income, revenue growth and notable return on equity. We feel these strengths outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated. Get the full
Amgen Ratings Report now.